Search research articles
Contact Us
Filters
Showing results (1-10 of 115) with videos related to
Page
of 12
Sort By:
Chemistry & Biodiversity
|
November 26, 2009
Transporters in absorption, distribution, and elimination
Jean-Michel Scherrmann
Clinical Pharmacology and Therapeutics
|
August 18, 2020
Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy
Jean-Michel Scherrmann
Expert Opinion on Drug Metabolism & Toxicology
|
August 23, 2006
Expression and function of multidrug resistance transporters at the blood-brain barriers
Jean-Michel Scherrmann
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
December 17, 2003
Peptide vectors as drug carriers
Jamal Temsamani, Jean-Michel Scherrmann
Joint Bone Spine
|
October 28, 2006
Colchicine today
Elisabeth Niel, Jean-Michel Scherrmann
Life Sciences
|
November 29, 2005
Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronide
Fanchon Bourasset, Jean-Michel Scherrmann
The Journal of Antimicrobial Chemotherapy
|
August 9, 2020
Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial
Bruno Mégarbane, Jean-Michel Scherrmann
Journal of Clinical Pharmacology
|
May 21, 2020
Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
Bruno Mégarbane, Jean-Michel Scherrmann
The AAPS Journal
|
December 17, 2008
Commentary: current advances and future directions for CNS delivery
Craig K Svensson, Jean-Michel Scherrmann
Biologie Aujourd'Hui
|
November 23, 2012
[Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier]
Aude Jacob, Xavier Declèves, Jean-Michel Scherrmann
Page
of 12
Search research articles
Search
Showing results (1-10 of 115) with videos related to
Sort By:
Page
of 12
Chemistry & Biodiversity
|
November 26, 2009
Transporters in absorption, distribution, and elimination
Jean-Michel Scherrmann
Clinical Pharmacology and Therapeutics
|
August 18, 2020
Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy
Jean-Michel Scherrmann
Expert Opinion on Drug Metabolism & Toxicology
|
August 23, 2006
Expression and function of multidrug resistance transporters at the blood-brain barriers
Jean-Michel Scherrmann
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
December 17, 2003
Peptide vectors as drug carriers
Jamal Temsamani, Jean-Michel Scherrmann
Joint Bone Spine
|
October 28, 2006
Colchicine today
Elisabeth Niel, Jean-Michel Scherrmann
Life Sciences
|
November 29, 2005
Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronide
Fanchon Bourasset, Jean-Michel Scherrmann
The Journal of Antimicrobial Chemotherapy
|
August 9, 2020
Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial
Bruno Mégarbane, Jean-Michel Scherrmann
Journal of Clinical Pharmacology
|
May 21, 2020
Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
Bruno Mégarbane, Jean-Michel Scherrmann
The AAPS Journal
|
December 17, 2008
Commentary: current advances and future directions for CNS delivery
Craig K Svensson, Jean-Michel Scherrmann
Biologie Aujourd'Hui
|
November 23, 2012
[Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier]
Aude Jacob, Xavier Declèves, Jean-Michel Scherrmann
Page
of 12